Indapamid Puren (Indapamide)

• Indapamide acts on the renal tubular system to control fluid balance and blood pressure, making it useful for several cardiovascular and renal conditions.
• Hypertension: lowers systemic blood pressure and reduces cardiovascular risk.
• Edema associated with heart failure: promotes fluid removal to relieve congestive symptoms.
• Edema due to renal or hepatic disease: assists in reducing excess extracellular fluid accumulation.

• Indapamide inhibits sodium‑chloride reabsorption in the distal convoluted tubule by blocking the Na⁺/Cl⁻ cotransporter. This natriuretic effect leads to increased urine output, a modest reduction in peripheral vascular resistance, and ultimately lower arterial pressure. The combined diuretic and vasodilatory actions contribute to its antihypertensive efficacy.

Indapamide may cause a range of adverse reactions, most of which are dose‑related and reversible.

Common Side Effects

• Increased urinary frequency: more frequent need to void.
• Dizziness or light‑headedness: especially after the first doses.
• Electrolyte disturbances: low potassium or sodium levels.
• Headache: mild to moderate intensity.
• Mild gastrointestinal upset: nausea or abdominal discomfort.

Serious or Rare Side Effects

• Severe electrolyte imbalance: hypokalemia or hyponatremia requiring medical attention.
• Acute kidney injury: sudden decline in renal function.
• Hyperuricemia or gout flare: elevated uric acid levels.
• Allergic reactions: rash, pruritus, or angioedema.
• Blood dyscrasias: rare cases of leukopenia or thrombocytopenia.

Before initiating therapy, clinicians should evaluate patient‑specific factors and monitor for potential complications.

• Renal function: assess baseline creatinine and monitor periodically.
• Electrolyte levels: check potassium, sodium, and magnesium regularly.
• Diabetes mellitus: monitor blood glucose as thiazide‑like agents may affect glycemic control.
• Hepatic impairment: use with caution in patients with severe liver disease.
• Concomitant antihypertensives: adjust doses to avoid excessive hypotension.
• Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Indapamide can interact with several drug classes, altering efficacy or safety.

Major Interactions (Avoid)

• Lithium: increased lithium levels may cause toxicity.
• Digoxin: enhanced digoxin concentrations can lead to arrhythmias.
• Cyclosporine: may raise cyclosporine levels and nephrotoxicity risk.

Moderate Interactions (Monitor Closely)

• NSAIDs: may reduce diuretic effect and impair renal function.
• ACE inhibitors or ARBs: combined use can potentiate hypotension and renal impairment.
• Beta‑blockers: additive blood pressure lowering effect.
• Corticosteroids: may exacerbate electrolyte loss.
• Antidiabetic agents: monitor glucose as diuretics can affect glycemic control.